Posttransplant Tacrolimus-Induced Diabetic Ketoacidosis: Review of the Literature
Diabetic ketoacidosis (DKA) in patients receiving tacrolimus as part of their immunosuppressive regimen is a rarely reported adverse event. We report a patient with autosomal dominant polycystic kidney disease (ADPKD) and no known history of diabetes mellitus who presented with DKA, 3 months after k...
Saved in:
| Main Authors: | Zaid Ammari, Stella C. Pak, Mohammed Ruzieh, Osama Dasa, Abhinav Tiwari, Juan C. Jaume, Maria A. Alfonso-Jaume |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Case Reports in Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2018/4606491 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tacrolimus Induced Diabetic Ketoacidosis Following Allogeneic Stem Cell Transplantation
by: Sanjeev Kumar Sharma, et al.
Published: (2014-08-01) -
Tacrolimus-Induced Diabetic Ketoacidosis (DKA) in Post Bone Marrow Transplant Patient
by: Omkar KALIDASRAO CHOUDHARI, et al.
Published: (2025-06-01) -
A rare but important adverse effect of tacrolimus in a heart transplant recipient: diabetic ketoacidosis
by: Zeynelabidin Öztürk, et al.
Published: (2015-10-01) -
Pathology of Ketoacidosis in Emergency of Diabetic Ketoacidosis and Alcoholic Ketoacidosis: A Retrospective Study
by: Katsumasa Koyama, et al.
Published: (2024-01-01) -
Euglycemic Diabetic Ketoacidosis in the ICU: 3 Case Reports and Review of Literature
by: Pablo Lucero, et al.
Published: (2018-01-01)